Home Home > Browse Locations > China

Find Paid Clinical Trials in Alabama

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in China

Top of Directory » All Locations » China




  • A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

    Condition:   Psoriasis
    Interventions:   Drug: ustekinumab;   Drug: placebo;   Drug: placebo;   Drug: ustekinumab
    Sponsor:   Centocor, Inc.
    Not yet recruiting - verified November 2009

  • Cross-Over Broccoli Sprouts Trial

    Condition:   Healthy
    Intervention:   Dietary Supplement: broccoli sprouts extract
    Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Qidong Liver Cancer Institute
    Recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Mucosal Barrier Defects in Functional Dyspepsia by Confocal Laser Endomicroscopy

    Condition:   Functional Dyspepsia
    Intervention:  
    Sponsor:   Shandong University
    Recruiting - verified November 2009

  • Intervention on Maternal Health Care in Rural China

    Condition:   Maternal Health
    Interventions:   Behavioral: clinical skills training;   Behavioral: health education;   Other: financial
    Sponsors:   National Institute for Health and Welfare, Finland;   Liverpool School of Tropical Medicine;   Karolinska Institutet;   University Ghent;   Fudan University;   Center for Health Statistics and Information;   Anhui Medical University;   Chongqing University of Medical Sciences;   Xi'an Jiaotong University;   Peking University
    Completed - verified October 2009

  • A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

    Condition:   Influenza
    Intervention:   Biological: H1N1 influenza A Vaccine (Split virion), Inactivated
    Sponsor:   Sinovac Biotech Co., Ltd
    Enrolling by invitation - verified October 2009

  • A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer

    Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Gemcitabine;   Drug: Cisplatin
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

    Condition:   Influenza
    Interventions:   Biological: H1N1 influenza A Vaccine (PANFLU.1);   Biological: Trivalent Inactivated Influenza Vaccine (ANFLU)
    Sponsor:   Sinovac Biotech Co., Ltd
    Recruiting - verified November 2009

  • Treating Apoplectic Sequela With Acupuncture: a Randomized Controlled Study

    Condition:   Cerebral Infarction
    Interventions:   Other: acupuncture;   Behavioral: rehabilitation;   Other: acupuncture and rehabilitation
    Sponsor:   Tianjin University of Traditional Chinese Medicine
    Recruiting - verified October 2009

  • A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

    Condition:   Osteosarcoma
    Interventions:   Drug: Chemotherapy;   Drug: Endostar
    Sponsor:   Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
    Recruiting - verified October 2009

  • Low Dose Cyclophosphamide Treats Genital Warts

    Condition:   Genital Wart
    Intervention:   Drug: cyclophosphamide
    Sponsor:   Huazhong University of Science and Technology
    Completed - verified October 2009

  • Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer

    Condition:   Hepatocellular Carcinoma
    Intervention:   Drug: Sorafenib
    Sponsor:   Fudan University
    Recruiting - verified October 2009

  • Shanghai Parkinson's Study

    Condition:   Parkinson's Disease
    Intervention:  
    Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
    Recruiting - verified September 2009

  • 10mg ZD4054 PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

    Condition:   Advanced Solid Malignancies
    Intervention:   Drug: ZD4054
    Sponsor:   AstraZeneca
    Recruiting - verified October 2009

  • Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

    Condition:   Coronary Artery Disease
    Interventions:   Device: everolimu-eluting stent;   Procedure: coronary artery bypass graft surgery
    Sponsors:   CardioVascular Research Foundation, Korea;   Abbott Vascular;   Boston Scientific Corporation
    Recruiting - verified October 2009

  • Assisted-VATS Sleeve Lobectomy With Bronchoplasty for Non-small Cell Lung Cancer

    Condition:   Non-small Cell Lung Cancer
    Intervention:   Procedure: a-VATS
    Sponsor:   The First Affiliated Hospital of Guangzhou Medical College
    Active, not recruiting - verified October 2009

  • Effect of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Post-exercise Expiratory Flow Volume in Healthy Subjects

    Condition:   Healthy
    Interventions:   Device: Acu-TENS;   Device: Placebo-TENS
    Sponsor:   The Hong Kong Polytechnic University
    Completed - verified October 2009

  • Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

    Conditions:   Potentially Resectable Liver Metastasis From CRC;   Colorectal Cancer
    Intervention:   Drug: Capecitabine plus oxaliplatin
    Sponsor:   Guangdong General Hospital
    Not yet recruiting - verified October 2009

  • Contrast-enhanced Magnetic Resonance Angiography Investigation of Intracranial Aneurysms and Prospective Study of Risk Factors

    Condition:   Intracranial Aneurysm
    Intervention:  
    Sponsor:   Second Military Medical University
    Enrolling by invitation - verified October 2009

  • Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

    Condition:   Essential Hypertension
    Interventions:   Drug: Exforge® 160/5mg;   Drug: Diovan® 160mg
    Sponsor:   Novartis
    Recruiting - verified October 2009

  • Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects

    Condition:   HPV-16/18 Infections.
    Interventions:   Biological: CervarixTM;   Other: Control
    Sponsor:   GlaxoSmithKline
    Recruiting - verified October 2009

  • Secondhand Smoke Exposure Reduction Among Young Children in China

    Conditions:   Secondhand Smoke Exposure;   Respiratory Illness;   Smoking Cessation
    Intervention:   Behavioral: SHI counseling
    Sponsors:   Boston University;   Fudan University School of Public Health, Shanghai, China
    Recruiting - verified October 2009

  • Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein

    Condition:   Liver Cirrhosis
    Interventions:   Procedure: Autologous BMSCs transplantation;   Drug: Conserved therapy
    Sponsor:   Sun Yat-sen University
    Active, not recruiting - verified October 2009

  • Effect of Alpha Lipoic Acid on Obesity Related Comorbidities

    Conditions:   Obesity;   Cardiovascular Disease;   Type 2 Diabetes
    Interventions:   Dietary Supplement: Alpha Lipoic Acid;   Dietary Supplement: Placebo
    Sponsors:   Medical College of Georgia;   Xinjiang Medical University, Urumqi, Xinjiang, China
    Recruiting - verified October 2009

  • Early Enteral Nutrition for Severe Acute Pancreatitis

    Condition:   Acute Necrotizing Pancreatitis
    Interventions:   Dietary Supplement: early enteral nutrition;   Dietary Supplement: Parenteral nutrition
    Sponsors:   Sichuan Academy of Medical Sciences;   Peking Union Medical College Hospital
    Recruiting - verified October 2009

  • Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas

    Condition:   Acromegaly
    Interventions:   Drug: Preoperative lanreotide treatment;   Procedure: Transsphenoidal surgery
    Sponsors:   Shanghai Jiao Tong University School of Medicine;   The First Affiliated Hospital of Sun Yat-sen University
    Recruiting - verified October 2009

  • Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

    Condition:   Hypertension
    Interventions:   Drug: Adalat (Nifedipine, BAYA1040);   Drug: Diovan (Valsartan)
    Sponsor:   Bayer
    Not yet recruiting - verified November 2009

  • Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer

    Condition:   Advanced Gastric Cancer
    Intervention:   Drug: cisplatin, Fluorouracil
    Sponsor:   Fudan University
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials